Rodolphe Barrangou

Is the Todd R. Klaenhammer Distinguished Professor in Probiotics Research in the Department of Food, Bioprocessing and Nutrition Sciences at North Carolina State University; Co-Founder and Chief Executive Officer of CRISPR Biotechnologies; Co-Founder and Chief Scientific Officer of Ancilia Biosciences; Co-Founder, President and Chief Scientific Officer of TreeCo; and Co-Founder and member of the Scientific Advisory Board of Intellia Therapeutics.

In 2017, Barrangou was named Editor-in-Chief of The CRISPR Journal.

He was elected as a member into the National Academy of Sciences in 2018.

He was also elected into the National Academy of Engineering in 2019 for the discovery of CRISPR-Cas genome editing and engineering microbes, plants, and animals for food.

He has been awarded 17 patents as of 2016.

2018 NAS Prize in Food and Agriculture Sciences;

2017 NAS Award in Molecular Biology;

2016 Canada Gairdner International Award;

2016 Warren Alpert Foundation Prize;

2015 Thomson Reuters Highly Cited Researcher;

2015 NC State University Faculty Scholar;

2014 NC State Alumni Association Outstanding Research Award recipient;

2014 Inducted into Phi Tau Sigma, the Honor Society for Food Science;

2011 NC State Food Science Outstanding Young Alumni award recipient;

2008 Danisco Innovation Award Recipient;

2003 National Science Foundation IGERT Fellow.